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INTRODUCTION
According	 to	 some	 recent	 surveys,	 diabetes	
mellitus	 is	one	of	 the	most	 frequently	diagnosed	
metabolic	 disorders	 both	 in	 animals	 and	 in	
humans	 (Wild	 et al.,	 2004;	 Guptill	 et al.,	 2003).	
Therefore,	 in	 a	 recent	 study	 regarding	 the	
prevalence	 of	 diabetes	 mellitus	 in	 2030,	 the	
diabetic	 population	 is	 estimated	 at	 366	 million	
(Wild	et al.,	2004).	Among	animals,	dogs	represent	
one	of	the	most	common	species	affected	by	this	
disease.	The	number	of	dogs	currently	diagnosed	
with	this	disease	has	jumped	to	64	out	of	10,000,	
while	 in	 the	 past	 19	 out	 of	 10,000	 dogs	 were	
affected	 by	 diabetes	 (Guptill	 et al.,	 2003).	 This	
metabolic	 condition	 caused	 by	 uncontrolled	
glycemia	 levels	 induces	 both	 acute	 and	 chronic	
complications	 (Kitabchi	 et al.,	 2009).	 Thus,	 a	
major	goal	of	researchers	 is	to	 find	non-invasive,	
easy-to-perform	 and	 economical	 methods	 for	
the	 investigation	 of	 diabetes	mellitus	 in	 animals	
and	 in	 humans.	 In	 the	 above	 view	 fluorescence	
spectroscopy	 is	 considered	 to	be	a	potential	 tool	
for	the	investigation	of	different	body	diseases,	as	
this	 technique	 presents	 a	 high	 sensitivity	 and	 is	
non-invasive	(Madhuri	et al.,	2003).	
Many	 biological	 tissues	 and	 fluids	 can	 be	
investigated	 by	 this	 technique.	 In	 the	 present	
study,	 we	 performed	 the	 spectrofluorimetric	
analysis	of	urine,	given	that	this	biological	fluid	is	
known	for	its	role	in	the	diagnosis	and	prognosis	of	
diseases	(Dubayova	et al.,	2003;	Anwer	et al.,	2009;	
Rajasekaran	 et al.,	 2013).	 In	 addition,	 due	 to	 its	
richness	in	metabolites,	the	majority	of	which	are	
recognized	as	fluorophores,	it	is	recommended	and	
used	 for	 spectrofluorimetric	 analysis (Dubayova	
et al.,	 2003;	 Kusnir	 et al.,	 2005;	 Perinchery	 et 
al.,	 2010;	 Anwer	 et al.,	 2009;	 Rajasekaran	 et al.,	
2013).	 Among	 these	 fluorophores,	 tryptophan	
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ABSTRACT
Diabetes	mellitus	is	one	of	the	most	common	metabolic	disorders	in	animals.	Thus,	currently,	it	is	imperative	
to	introduce	non-invasive,	economical	and	rapid	methods	for	the	investigation	of	diabetes	in	animals.	In	this	study,	
the	urine	samples	collected	from	10	non-diabetic	and	10	streptozotocin-induced	diabetic	rats	were	investigated	
by	 the	 spectrofluorimetric	 technique.	 Emission	 spectra	 for	 the	 urine	 samples	 were	 obtained	 following	 an	
excitation	wavelength	of	280	and	400	nm.	The	investigated	fluorophores	were	mainly	tryptophan	metabolites,	and	
significant	differences	resulted	between	the	mean	heights	of	the	emission	bands	attributed	to	these	fluorophore	
compounds	 in	diabetic	 compared	 to	non-diabetic	 rats.	The	 shape	of	 the	 spectral	windings	after	 the	utilization	
of	these	two	excitation	wavelengths	was	almost	similar	for	diabetic	and	non-diabetic	rats;	however,	there	were	
some	discriminatory	elements	between	the	two	types	of	investigated	samples.	In	conclusion,	the	obtained	urine	
fluorescence	spectra	allow	a	clear	differentiation	between	diabetic	and	non-diabetic	rats.
Keywords: urine, spectrofluorimetry, diabetes, tryptophan, urinary metabolites.
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metabolites	 are	 the	 most	 studied	 due	 to	 their	
capabilities	to	show	alterations	in	some	metabolic	
processes	 (Perincheri	 et al.,	 2010;	 Saude	 et 
al.,	 2007).	 Despite	 the	 fact	 that	 numerous	
studies	 have	 analyzed	 the	 pathobiochemical	
characteristics	of	urine	by	means	of	fluorescence	
spectroscopy	(Dubayova	et al.	2003),	the	study	of	
the	fluorescence	of	urine	for	diabetes	diagnosis	in	
particular	and	disease	diagnosis	in	general	is	still	
at	the	beginning,	as	evidenced	in	a	recent	research	
article	(Rajasekaran	et al.,	2013). 
Therefore,	in	our	study,	we	used	fluorescence	
spectroscopy	in	order	to	investigate	the	differences	
between	 the	 emission	 spectra	 of	 urine	 collected	
from	 non-diabetic	 rats	 and	 streptozotocin-
induced	diabetic	rats. At	the	same	time,	we	tried	
to	establish	the	excitation	wavelength	allowing	to	
make	the	most	significant	difference	between	the	
two	 groups	 of	 rats.	 Another	 important	 aspect	 of	
our	study	was	the	assignment	of	main	fluorescence	
spectral	 bands	 to	 some	 urine	 compounds	
according	to	known	literature	data.	Furthermore,	
we	evaluated	the	height	of	these	emission	bands	in	
diabetic	compared	to	non-diabetic	rats.	
MATERIALS AND METHOD
Animals: We	used	10	rats	(8	middle-aged	and	
2	young	rats),	weighing	between	350-500	g.	They	
were	 housed	 in	 two	 stainless	 cages,	 each	 cage	
containing	5	rats.	The	rats	were	given	ad	libitum	
access	 to	 food	 and	 water.	 Before	 induction	 of	
diabetes,	fasting	blood	glucose	was	monitored	and	
ranged	between	135±5	mg/dl	(Akbarzadeh	et al.,	
2007).	24-hour	urine	samples	were	collected	from	
all	rats	included	in	the	control	group.	
Urine sample collection: Urine	samples	from	
non-diabetic	 rats	were	 collected	 during	 the	 first	
five	days	of	the	experiment.	Each	rat	belonging	to	
the	 control	 group	was	placed	 in	metabolic	 cages	
over	 a	 24	 hours	 period	 and	 urine	was	 collected.	
Diabetes	 was	 induced	 immediately	 after	 the	
collection	of	urine	samples.	In	order	to	correct	the	
excessive	amount	of	glucose	in	the	blood	plasma,	
on	day	2	after	 induction	of	diabetes,	 insulin	was	
administered.	The	urine	of	two	diabetic	rats	(n=2)	
was	analyzed	on	the	first	day	(U
0
)	after	induction	
of	diabetes,	and	the	rest	of	the	samples	(n=8)	were	
collected	after	 administration	of	 a	 single	dose	of	
insulin	(from	day	3	to	day	6)	(U
3-6
).	
Induction of diabetes: We	used	streptozotocin	
for	the	induction	of	experimental	diabetes	in	rats.	
This	drug	is	a	synthetic	antineoplastic	agent	and	is	
classified	as	an	antitumor	and	chemical	antibiotic.	
In	 the	 literature,	 it	 is	 recognized	 that	 this	 drug	
induces	 experimental	 diabetes	 in	 three	 days	 by	
destruction	 of	 pancreatic	 β-cells	 (Akbarzadeh	 et 
al.,	2007).	In	this	study,	we	used	a	dose	of	60	mg/
kg	 that	 was	 administered	 intravenously.	 In	 just	
three	days	after	streptozotocin	administration,	the	
rats	with	plasma	glucose	concentrations	between	
300-500	mg/dl	were	considered	diabetic	(Kim	et 
al.,	 2007).	 The	 study	 protocol	 was	 approved	 by	
the	 local	 Ethics	 Committee	 of	 the	 University	 of	
Agricultural	 Sciences	 and	 Veterinary	 Medicine,	
Cluj-Napoca,	Romania.
Spectrofluorimetric analysis: The	 spectro-
fluori	metric	 analysis	 of	 urine	 from	 non-diabetic	
(n=10)	 and	 diabetic	 rats	 (n=10)	 was	 performed	
with	 a	 Jasco	 FP	 8200	 spectrofluorometer.	 We	
analyzed	2	ml	of	urine	without	prior	centrifugation.	
In	order	to	obtain	not	only	a	proper	emission	for	
the	 investigated	 urinary	 fluorophores,	 but	 also	
a	 good	 comparison	 between	 the	 urine	 samples	
collected	from	non-diabetic	and	diabetic	rats,	we	
used	 several	 excitation	 wavelengths	 (280,	 335,	
370	 and	 400	 nm).	 In	 this	 study,	 we	 presented	
the	 differences	 between	 the	 fluorescence	 of	
urine	collected	 from	the	 two	groups	of	rats	after	
performing	an	excitation	with	a	wavelength	of	280	
and	400	nm.	The	emission	spectra	were	recorded	
in	a	 range	 from	320	 to	600	nm	and	 from	420	 to	
650	 nm,	 respectively.	 The	 fluorescence	 data	
analysis	was	performed	using	the	Origin	Pro	8.5.1	
software.
Statistical analysis: Data	 analyses	 were	
made	 using	 the	 software	 R	 2.15.1	 for	Windows.	
In	 order	 to	 describe	 the	 normal	 distribution	 of	
variables,	the	Kolmogorov-Smirnov	test	was	used.	
Normally	 distributed	 and	 continuous	 data	 were	
characterized	 by	 means±standard	 deviation.	
Group	 comparison	 was	 made	 using	 the	 T-test.	A p	 value	 <0.05	 was	 considered	 statistically	
significant.	
RESULTS AND DISCUSSIONS
Description of the rats included in the study
The	 characteristics	 of	 the	 rats,	 including	
age	 and	 weight,	 were	 provided	 in	 the	 section	
material	and	methods.	Blood	glucose	 levels	were	
significantly	 higher	 in	 all	 diabetic	 rats	 when	
compared	with	 non-diabetic	 controls	 (104.4±4.6	
mg/dl	vs. 367.7±110.2	mg/dl;	p<0.001).		
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The use of an excitation wavelength of 280 nm
After	performing	the	excitation	at	280	nm,	the	
emission	 spectra	 of	 the	 urine	 samples	 collected	
from	both	diabetic	and	non-diabetic	rats	presented	
five	emission	bands,	as	follows:	at	approximately	
420,	 446,	 467,	 490	 and	 520	 nm,	 respectively	
(Figure	1(A)	and	(B)).	
Compared	 with	 the	 control	 group,	 higher	
emission	 bands	 were	 found	 in	 the	 rats	 with	
induced	 diabetes	 (Figure	 1(A)	 and	 (B)).	 In	
addition,	from	Figure	1(A)	it	can	be	observed	that	
the	fluorescence	emission	spectra	of	normal	urine	
also	have	a	shoulder	around	420	nm.	In	the	case	
of	 diseased	 conditions,	 the	 weak	 band	 of	 ~420	
nm	is	considerably	shifted	with	a	prominent	peak	
around	400	nm.	Therefore,	there	is	a	20	nm	shift	
with	 respect	 to	 normal	 urine.	 Rajasekaran	 et al. 
(2014)	reported	that	the	peak	at	around	400	nm	
can	 be	 attributed	 to	 the	 tryptophan	 metabolite	
indoxyl	 sulfate.	 In	 diabetic	 rats,	 the	mean	 of	 the	
peak	height	around	400	nm	was	1312.30±175.194,	
while	 in	 the	 case	 of	 non-diabetic	 rats	 the	 mean	
for	 the	 peak	 height	 at	 around	 420	 nm	 was	
135.10±47.17.	A	significant	difference	was	 found	
between	 these	 two	 means	 (p<0.001).	 Similarly,	
the	 average	 of	 the	 peak	 height	 around	 446	 nm	
(1207.40±839.38	 vs.	 370.10±271.71,	 p<0.05)	
and	467	nm	(1131.50±885.02 vs. 469.90±270.68,	
p<0.05)	 was	 significantly	 higher	 in	 diabetic	 rats	
compared	 to	 non-diabetic	 rats.	 In	 contrast,	 no 
statistically significant difference	 was	 determined	
between	the	groups	 for	 the	peaks	at	around	490	
(1028.50±835.03	 vs.	 499.90±245.53,	 p=0.134)	
and	 520	 nm	 (619.30±488.38	 vs.	 341.50±151.05,	
p=0.179).	 In	 an	 attempt	 to	 characterize	 the	
fluorescence	 of	 urine	 by	 using	 an	 excitation	 of	
290±10	 nm,	 Anwer	 et al.	 (2009)	 reported	 that	
tryptophan	 and	 its	 metabolites	 are	 the	 main	
fluorophores	which	 are	 excited	 at	 this	 excitation	
wavelength.	 In	 addition,	 it	 was	 reported	 that	
the	 band	 around	 520	 nm	 may	 be	 attributed	 to	
riboflavin	(Rajasekaran	et al.,	2014).								
The use of an excitation wavelength of 400 nm 
From	Figure	2(A)	it	can	be	seen	that	the	urine	
emission	 spectra	 of	 non-diabetic	 rats	 excited	 at	
400	nm	present	six	emission	bands,	as	follows:	at	
approximately	 450,	 486,	 525,	 555,	 578	 and	 615	
nm,	respectively.	 It	can	also	be	observed	that	the	
urine	spectra	of	diabetic	rats	(Figure	2(B))	present	
five	 emission	 bands:	 at	 approximately	 450,	 486,	
525,	555	and	615	nm,	respectively.	
The	 mean	 (±standard	 deviation)	 and	 the	 p 
values	 of	 the	 peak	 height	 for	 the	 urine	 samples	
of	 diabetic	 and	 non-diabetic	 rats	 are	 presented	
Fig. 1.	Urine	fluorescence	emission	spectra	of	non-diabetic	(A)	and	diabetic	rats	(B)	
excited	at	280	nm.	The	spectra	were	recorded	in	a	range	from	350	to	600	nm.	
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in	 Table	 1.	 The	 p	 values	 provided	 in	 this	 table	
(p≤0.05)	show	a	statistical	significance	for	all	the	
investigated	variables.				
To	further	attribute	the	emission	wavelengths	
at	 the	excitation	of	400	nm,	 it	has	been	reported	
that	 the	 peak	 at	 ~444	 nm	may	 be	 attributed	 to	
bound	NADH	(nicotinamide	adenine	dinucleotide),	
and	 the	 band	 at	 ~485	 nm	 is	 due	 to	 free	 NADH	
(Rajasekaran	et al.,	2013;	Masilamani	et al.,	2010;	
Wolfbeis	and	Leiner,	1985).	The	bands	centered	at	
~525	and	~615	nm			are	mostly	due	to	flavin	and	
porphyrins	(Rajasekaran	et al.,	2013;	Masilamani	
et al.,	2010;	Wolfbeis	and	Leiner,	1985).	
From	 fluorescence	 measurements,	 it	 can	 be	
observed	 that	 for	 the	 excitation	 of	 400	 nm,	 the	
spectral	 shape	 is	 almost	 similar	 in	 diabetic	 and	
non-diabetic	 rats.	 The	 urine	 emission	 spectra	 of	
non-diabetic	 rats	 have	 a	 major	 peak	 at	 around	
486	nm	with	some	small	humps	at	450,	530,	560	
and	615	nm,	respectively.	On	the	other	hand,	the	
emission	spectra	of	urine	from	diabetic	rats	have	a	
primary	peak	at	around	450	nm,	with	the	presence	
of	some	small	humps	at	486,	530,	560	and	615	nm,	
respectively.	 This	may	be	due	 to	 the	 variation	 in	
the	 contribution	of	 free	 and	bound	NADH	 to	 the	
total	fluorescence	of	urine	from	diabetic	and	non-
diabetic	 rats.	As	 can	be	 seen	 in	Figure	2a	 and	b,	
Fig. 2.	Urine	fluorescence	emission	spectra	of	non-diabetic	(A)	and	diabetic	rats	(B)	
excited	at	400	nm.	The	spectra	were	recorded	in	a	range	from	420	to	650	nm.
Tab.1.	Mean,	standard	deviation	and	p	values	for	the	investigated	peak	height	(excitation	wavelength	of	
400	nm)
Emission	
wavelength	(nm)
Non-diabetic	rats Diabetic	rats p	value
450 480±323 3034±2266 0.003	
485 918.10±548.504 3619.50±1540.27 ˂0.05	
525 503.40±275.44 2034.40±644.57 ˂0.05	
555 228.10±118.96 959.10±328.15 ˂0.05	
615 58.70±33.24 224.80±61.53 ˂0.05	
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the	fluorescence	intensity	of	free	NADH	(the	band	
at	 around	 444	 nm)	 is	 affected	 in	 diabetic	 rats	
compared	to	non-diabetic	rats.	This	is	because	the	
healthy	glomerulus	of	non-diabetic	rats	can	filter	
the	 free	 NADH	 and	 therefore,	 this	 can	 be	 found	
in	urine	(Rajasekaran	et al.,	2013;	Gropper	et al.,	
2009).	In	this	context,	in	the	case	of	non-diabetic	
rats,	the	fluorescence	of	urine	is	enhanced	by	the	
presence	of	more	 free	NADH.	Another	 important	
aspect	 is	 the	 small	 hump	 around	 578	 nm	 in	 the	
spectra	 of	 urine	 samples	 from	non-diabetic	 rats,	
which	 is	 almost	 absent	 in	 the	 case	 of	 diabetic	
rats	 (Figure	 2	 a,b).	 Based	 on	 the	 literature	 data,	
the	 peak	 assignment	 was	 not	 yet	 possible.	 This	
spectral	 characteristic	 was	 also	 observed	 in	 the	
study	 of	 Rajasekaran	 et al.	 (2013);	 the	 small	
band	at	580	nm	was	present	in	the	urine	spectra	
of	healthy	patients	and	was	absent	in	the	case	of	
diseased	subjects.	
Fluorescence	 measurements	 also	 show	 that	
the	 emission	 intensities	 of	 urine	 metabolites	
before	and	after	insulin	administration	are	higher	
in	 diabetic	 rats	 compared	 to	 controls	 (Figures	
1(A)	and	1(B),	Figures	2(A)	and	2(B)).		Moreover,	
the	 urine	 emission	 spectra	 of	 streptozotocin-
induced	diabetic	rats	(Figures	1(B)	and	2(B))	are	
strongly	 influenced	 by	 insulin	 administration.	
Therefore,	 it	 can	 be	 easily	 observed	 that	 after	
insulin	 administration,	 the	 emission	 intensities	
of	urine	fluorophores	have	decreased.	The	reason	
for	these	variations	in	fluorescence	intensity	may	
be	the	insulin	capacity	to	quench	intrinsic	protein	
fluorescence	(Bekard	and	Dunstan,	2009).	 It	was	
reported	 that	 this	 hypoglycemic	 agent	 has	 three	
native	 disulfide	 bonds	 in	 its	 composition	 which	
are	responsible	for	this	ability	(Permyakov,	1992).	
CONCLUSION
In	 conclusion,	 the	 fluorescence	 emission	
spectra	excited	at	280	and	400	nm	allow	making	
important	 differences	 between	 the	 urine	
samples	collected	from	non-diabetic	and	diabetic	
rats.	 Moreover,	 we	 could	 mention	 an	 altered	
metabolism	of	 urine	 fluorophores	 (NADH,	 flavin,	
porphyrins,	 indoxyl	 sulfate)	 in	 streptozotocin-
induced	 diabetic	 rats,	 since	 their	 synthesis	 and	
excretion	 are	 augmented	 in	 the	 case	 of	 diabetic	
rats	compared	to	non-diabetic	rats.			
REFERENCES
1.	 Akbarzadeh	 A,	 Norouzian	 D,	 Mehrabi	 MR,	 Jamashidi	
SH,	Farhangi	 	A,	Allah	Verdi	A,	Mofidian	SMA,	Lame	Rad	
B	 (2007).	 Induction	 of	 diabetes	 by	 Streptozotocin	 in	
rats. Indian	Journal	of	Clinical	Biochemistry,	22:60-64.
2.	 Anwer	A	G,	Sandeep	PM,	Goldys	EM,	Vemulpad S	(2009).	
Distinctive	 autofluorescence	 of	 urine	 samples	 from	
individuals	with	bacteriuria	compared	with	normals.	Clin.	
Chim.	Acta,	401:73–75.
3.	 Bekard	IB,	Dunstan	DE	(2009).	Tyrosine	Autofluorescence	
as	 a	Measure	 of	 Bovine	 Insulin	 Fibrillation.	 Biophysical	
Journal,		97:2521-2531.	
4.	 Dubayova	 K,	 Kusnir	 J,	 Podracka	 	 L	 (2003).	 Diagnostic	
monitoring	of	urine	by	means	of	synchronous	fluorescence	
spectrum.	J.	Biochem.	Biophys.	Methods,	55:111–119.
5.	 Gropper	 SS,	 Smith	 JL,	 Groff	 JL	 (2009).	 Water-soluble	
vitamins.	 In	 Advance	 Nutrition	 and	 Human	Metabolism	
(Edited	by	P.	Adams,	A.	Lustig,	E.	Feldman	and	E.	Downs),	
pp.	 329–333.	 Wadsworth,	 Cengage	 Learning,	 Belmont,	
CA.
6.	 Guptill	 L,	 Glickman	 L,	 Glickman	 N	 (2003).	 Time	 trends	
and	risk	factors	for	diabetes	mellitus	in	dogs:	analysis	of	
veterinary	 medical	 database	 records	 (1970–1999).	 Vet	
Journal,	165:240–247.
7.	 Kim	YS,	Kim	NH,	Lee	SW,	Lee	YM,	Jang	DS,	Kim	JS	(2007).	
Effect	of	protocatechualdehyde	on	receptor	for	advanced	
glycation	 end	 products	 and	 TGF-beta1	 expression	 in	
human	 lens	 epithelial	 cells	 cultured	 under	 diabetic	
conditions	and	on	lens	opacity	in	streptozotocin-diabetic	
rats.	European	Journal	of	Pharmacology,	569:171-9.
8.	 Kitabchi	 AE,	 Umpierrez	 GE,	 Miles	 JM,	 Fisher	 JN	
(2009).	 Hyperglycemic	 Crises	 in	 Adult	 Patients	 With	
Diabetes.	Diabetes	Care,	32:1335-1343.
9. Kušnír J, Dubayová K, Lešková L, Lajtár M (2005). 
Concentration	 Matrices—Solutions	 for	 Fluorescence	
Definition	of	Urine.	Analytical Letters, 38:1559-1567.	
10.	Madhuri	 S,	 Vengadesan	 N,	 Aruna	 P,	 Koteeswaran	 D,	
Venkatesan	 P,	 Ganesan	 S	 (2003).	 Native	 fluorescence	
spectroscopy	of	 blood	plasma	 in	 the	 characterization	of	
oral	malignancy.	Photochem.	Photobiol.,	78:197–202.
11.	Masilamani	V,	Vijmasi	T,	Al	Salhi	M,	Govindaraj	K,	Vijaya-
Raghavan	AP,	Antonisamy	B (2010).	Cancer	detection	by	
native	fluorescence	of	urine.	J	Biomed	Opt.,	15:057003.
12.	Perinchery	 SM,	 Kuzhiumparambil	 U,	 Vemulpad	 S,	
Goldys	 EM	 (2010).	 The	 potential	 of	 autofluorescence	
spectroscopy	 to	 detect	 human	 urinary	 tract	 infection.	
Talanta,	82:912–917.
13.	Permyakov	E.A,	(1992)		editor.	Luminiscent	Spectroscopy	
of	Proteins.CRC	Press,	London.
14.	Rajasekaran	R,	Aruna	PR,	Koteeswaran	D,	Padmanabhan	
L,	Muthuvelu	K,	Rai	RR,	Thamilkumar	P,	Murali	Krishna	
C,	 Ganesan	 S (2013).	 Characterization	 and	 diagnosis	 of	
cancer	 by	 native	 fluorescence	 spectroscopy	 of	 human	
urine.	Photochem	Photobiol.,	89:483-91.
15.	Rajasekaran	R,	Aruna	PR,	Koteeswaran	D,	Bharanidharan	
G,	Baludavid	M,	Ganesan	S	(2014).	Steady-state	and	time-
resolved	 fluorescence	 spectroscopic	 characterization	 of	
Evaluation	of	Urinary	Tryptophan	Metabolite	Levels	in	Non-diabetic	Compared	to	Diabetic	Rats
178
Bulletin UASVM Veterinary Medicine 74 (2) / 2017
urine	 of	 healthy	 subjects	 and	 cervical	 cancer	 patients.	 J	
Biomed	Opt.,	19:37003.
16.	Saude	 EJ,	 Adamko	 D,	 Rowe	 BH,	 Marrie	 T,	 Sykes	 BD	
(2007).	Variation	of	metabolites	in	normal	human	urine.	
Metabolomics,	3:439–451. 
17.	Wild	S,	Roglic	G,	Green	A,	Sicree	R,	King	H	(2004).	Global	
prevalence	of	diabetes:	estimates	 for	 the	year	2000	and	
projections	for	2030.	Diabetes	Care,	27:1047-53.
18.	Wolfbeis	 OS,	 Leiner	 M	 (1985).	 Mapping	 of	 the	 total	
fluorescence	of	human	blood	serum	as	a	new	method	for	
its	characterization.	Anal.	Chim.	Acta,	167:203–215.
OLAR et al
